Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3041073

C1=CCC([Hf+2]c2cccc3c2Cc2ccccc2-3)=C1.[Cl-].[Cl-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
HTR7 P34969 1/20 0.33
HTR2B P41595 1/20 0.33
PGR P06401 1/20 0.32
MAP3K9 P80192 1/20 0.30
MAP3K11 Q16584 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL7921884 0.97 PNMT (0.39) PNMTNPC1RAB9ADRD2DRD4
Bromide SCHEMBL7939131 0.97 PNMT (0.39) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL29695725 0.81 PNMT (0.50) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL816978 0.81 PNMT (0.50) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL9412846 0.79 MAPT (0.39) NPC1RAB9ADRD2DRD3MAP3K9
SCHEMBL8379134 0.78 PNMT (0.50) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL4890082 0.75 PNMT (0.37) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL27425148 0.73 PNMT (0.42) PNMTNPC1RAB9ADRD2DRD4
SCHEMBL27348144 0.72 PNMT (0.45) PNMTNPC1RAB9ADRD2DRD4
SCHEMBL28220071 0.71 PNMT (0.44) PNMTNPC1RAB9ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736358-A Metallocene polyethylene for sintering and preparation method and application thereof 上海化工研究院有限公司 2024-03-22 CN disclosed
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-05-11 US disclosed
WO-2021194831-A1 ALKYLATION OF TRANSITION METAL COORDINATION CATALYST COMPLEXES EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-09-30 WO disclosed
EP-1880986-B1 PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBONS, AND LUBRICANT COMPOSITIONS THEREOF IDEMITSU KOSAN CO (JP) 2013-03-06 EP disclosed
EP-2222723-B1 METHOD FOR CONTROLLING BIMODAL CATALYST ACTIVITY DURING POLYMERIZATION UNIVATION TECH LLC (US) 2013-02-27 EP disclosed
US-8373011-B2 Used in a base oil of lubricant having good low temperature fluidity, low evaporativity, and thermal stability and oxidation stability IDEMITSU KOSAN CO., LTD. (JP) 2013-02-12 US disclosed
US-8318872-B2 Method for controlling bimodal catalyst activity during polymerization UNIVATION TECHNOLOGIES, LLC (US) 2012-11-27 US disclosed
EP-2222723-A2 METHOD FOR CONTROLLING BIMODAL CATALYST ACTIVITY DURING POLYMERIZATION Univation Technologies, LLC (US) 2010-09-01 EP disclosed
US-7785735-B2 Microporous composite membrane and its producing method and use TONEN CHEMICAL CORPORATION (JP) 2010-08-31 US disclosed
EP-1693408-B1 MICROPOROUS COMPOSITE FILM, PROCESS FOR PRODUCING THE SAME, AND USE TONEN SEKIYUKAGAKU KK (JP) 2010-04-14 EP disclosed
WO-1998037101-A1 IMPROVED CONTROL OF SOLUTION CATALYST DROPLET SIZE WITH AN EFFERVESCENT SPRAY NOZZLE UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-08-27 WO disclosed
WO-1998030608-A1 METHOD OF CONTROLLING OLEFIN POLYMERIZATION CATALYST COMPOSITION ACTIVITY UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-07-16 WO disclosed
WO-1998030606-A1 OLEFIN POLYMERIZATION CATALYST COMPOSITION HAVING INCREASED ACTIVITY UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-07-16 WO disclosed
WO-1998028350-A1 HIGH ACTIVITY METALLOCENE POLYMERIZATION PROCESS EXXON CHEMICAL PATENTS INC. (US) 1998-07-02 WO disclosed
EP-0811637-A2 Method for feeding a liquid catalyst to a fluidized bed polmerization reactor UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-12-10 EP disclosed
EP-0811638-A2 Process for controlling static in polymerizations utilizing metallocene catalysts UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-12-10 EP disclosed
US-5693727-A INTRODUCING MONOMERS INTO POLYMERIZATION ZONE CONTAINING BED OF GROWING POLYMER PARTICLES, INTRODUCING UNSUPPORTED POLYMERIZATION CATALYST IN LIQUID FORM INTO VESSEL, WITHDRAWING POLYMERIC PRODUCT, UNREACTED MONOMERS, GASES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-12-02 US disclosed
EP-0768320-A1 Catalyst component and catalyst NIPPON OIL CO. LTD. (JP) 1997-04-16 EP disclosed
US-5476914-A Highly crystalline; comprising a high percentage of racemic dyads FINA TECHNOLOGY, INC. (US) 1995-12-19 US disclosed
US-5132381-A Aluminoxane, Hafnium Metallocene HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes AS3MT, AP1M1, AP3M1 PNMT 1288/4885NPC1 1405/4885RAB9A 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.